Andreas Osanger

Director - Therapeutic Area Lead Nephrology - CSL Vifor

Andreas Osanger has an academic life science background and completed his studies of Biotechnology as PhD in Vienna, Austria (University of Natural Resources and Life Sciences). Subsequently, he started his pharmaceutical career in a Contract Research Organization located in Munich (Germany). Since 2008, Andreas is a member of the Global Drug Safety and Risk Management team at CSL Vifor in Zurich (Switzerland). Currently, Andreas is acting as the Drug Safety Therapeutic Area Lead for Nephrology. Andreas has broad experience in managing drug safety processes during clinical development programs and is well familiar with post-marketing pharmacovigilance processes. Lately, he is also been actively involved in cross-functional benefit-risk strategy management. Working for a pharmaceutical company with a growing portfolio and in-licensing activities, Andreas also gained multiple experiences in building PV partnerships from scratch.

Andreas Osanger


  • Tuesday - November 22, 2022 - 09:45

    Ways to build successful PV partnerships in in-licensing scenarios and the role of PV in due-diligence processes

      Watch Session   Presentation

  • Tuesday - November 22, 2022 - 11:10

    Panel Discussion - An Integrated care: Effective Implementation of vigilances systems

    • Separated vigilance systems can lead to the emergence of divergence in terms, definitions, variety of reporting forms and methods and the build of specific databases where cross analysis is no more possible.
    • To be more proactive and innovative in PV and to ensure that emerging problems are promptly recognized and solutions are effectively communicated
    • This integrated approach is very useful, especially for emerging countries to strengthen regulatory processes and to promote high standards of product vigilance for the protection of the health and safety of Citizens

      Watch Session


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now